FDA Approves First Automated Test for Neuroendocrine Tumour

Thermo Fisher Scientific, a global leader in scientific services, has received FDA clearance for the Thermo Scientific™ B·R·A·H·M·S™ CgA II KRYPTOR™ immunoassay, marking the first FDA-approved chromogranin A (CgA) test. Click to read more...

Related Keywords

United States , Tina Liedtky , National Cancer Institute Surveillance , End Results Program , Thermo Fisher , Thermo Fisher Scientific , Thermo Scientific , National Cancer Institute , Clinical Diagnostics , Nobel Prize Winning , Thermo , Cientific , Fisher , Mmunoaay , Humour , Clearance , Pest , Rogreion , Neuroendocrine , Developing ,